Abstract: The present invention relates to indanone compounds. The indanone compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes obesity dyslipidemia and related disorders. The invention furthermore relates to the use of indanone compounds as active ingredients in pharmaceuticals and pharmaceutical compositions comprising them.
| # | Name | Date |
|---|---|---|
| 1 | 201637027246-AbandonedLetter.pdf | 2020-02-17 |
| 1 | Form 5 [09-08-2016(online)].pdf | 2016-08-09 |
| 2 | 201637027246-FER.pdf | 2019-06-28 |
| 2 | Form 3 [09-08-2016(online)].pdf | 2016-08-09 |
| 3 | Form 1 [09-08-2016(online)].pdf | 2016-08-09 |
| 3 | 201637027246-FORM 18 [19-03-2018(online)].pdf | 2018-03-19 |
| 4 | Form 3 [02-02-2017(online)].pdf | 2017-02-02 |
| 4 | Description(Complete) [09-08-2016(online)].pdf | 2016-08-09 |
| 5 | Form 3 [31-01-2017(online)].pdf | 2017-01-31 |
| 5 | Other Patent Document [03-11-2016(online)].pdf | 2016-11-03 |
| 6 | Other Patent Document [31-01-2017(online)].pdf | 2017-01-31 |
| 7 | Form 3 [31-01-2017(online)].pdf | 2017-01-31 |
| 7 | Other Patent Document [03-11-2016(online)].pdf | 2016-11-03 |
| 8 | Description(Complete) [09-08-2016(online)].pdf | 2016-08-09 |
| 8 | Form 3 [02-02-2017(online)].pdf | 2017-02-02 |
| 9 | 201637027246-FORM 18 [19-03-2018(online)].pdf | 2018-03-19 |
| 9 | Form 1 [09-08-2016(online)].pdf | 2016-08-09 |
| 10 | Form 3 [09-08-2016(online)].pdf | 2016-08-09 |
| 10 | 201637027246-FER.pdf | 2019-06-28 |
| 11 | Form 5 [09-08-2016(online)].pdf | 2016-08-09 |
| 11 | 201637027246-AbandonedLetter.pdf | 2020-02-17 |
| 1 | SearchStrategy201637027246_27-06-2019.pdf |